Despite this, many novel inhibitors of FDFT1 (summarized in Table 2) have proven effectiveness in reducing cholesterol synthesis and may offer future potential in cancer treatment [237,238,239,240,241,242,243,244,245,246,247]. Here, FDFT1 is linked to cancer.